Trademark: 79070961
Word
SEIKAGAKU
Status Date
Wednesday, December 22, 2021
Registration Number
3983398
Registration Date
Tuesday, June 28, 2011
Filing Date
Friday, March 13, 2009
Published for Opposition
Tuesday, April 12, 2011
5 (( Joint function improving agents, namely, pharmaceutical preparations for treating arthrosis and other joint diseases; [ Ophthalmic surgical aid, namely, sodium hyaluronate solution used for surgery in and around the eyes; Pharmaceutical preparations for the treatment of disc hernia; ] Syringes sold filled with pharmaceuticals, namely, crosslinked or non-crosslinked hyaluronic acid based gel for the treatment of arthrosis and osteoarthritis; Syringes sold filled with pharmaceuticals, namely, sodium hyaluronate solutions for the treatment of arthrosis and osteoarthritis )) [ ; Diagnostic preparations for medical purposes for detecting mycosis; Diagnostic preparations for medical purposes, namely, diagnostic reagents for in-vitro clinical diagnostic purposes ]
1 (( [ Hyaluronic acid and salts of hyaluronic acid as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, namely, tissue-engineered products, artificial skin products, artificial vitreous body products and anti-adhesive products, and for research purposes in the biomedical field; ] )) Chondroitin sulfate and salts of chondoroitin sulfate as raw materials for use in the production of (( pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, namely, tissue-engineered products, )) artificial skin products and corneal preservation medium, and for research purposes in the biomedical field; Chemical reagents for scientific, research and quality control purposes, namely, limulus amebocyte lysate reagents for use in analysis of endotoxins (( [ and beta-glucan; Reagents, namely, glycobiological analysis reagents for clinical and medical laboratory use, and diagnostic preparations and reagents for clinical and medical laboratory use ] ))
10 [ Injection syringes ; Injection needles ]
The mark consists of the literal element "SEIKAGAKU" and a design consisting of two oblong intersections shapes canted to the right and in the form of capsules.
Color is not claimed as a feature of the mark.
The English translation of "SEIKAGAKU" in the mark is "BIOCHEMISTRY".
The stippling is for shading purposes only.
Oct 24, 2022
Partial Invalidation Processed By The Ib
Sep 26, 2022
Partial Invalidation Of Reg Ext Protection Sent To Ib
Sep 26, 2022
Invalidation Processed
Aug 22, 2022
Partial Invalidation Of Reg Ext Protection Created
Dec 22, 2021
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Dec 22, 2021
Registered - Partial Sec. 71 Accepted & Sec. 15 Ack.
Dec 8, 2021
Case Assigned To Post Registration Paralegal
Jun 16, 2021
Teas Section 71 & 15 Received
Jun 28, 2020
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Mar 28, 2019
International Registration Renewed
Apr 13, 2018
Partial Invalidation Processed By The Ib
Mar 8, 2018
Partial Invalidation Of Reg Ext Protection Sent To Ib
Mar 8, 2018
Invalidation Processed
Feb 26, 2018
Partial Invalidation Of Reg Ext Protection Created
Jun 26, 2017
Notice Of Acceptance Of Sec. 71 - E-Mailed
Jun 26, 2017
Sec. 15 Acknowledgement - E-Mailed
Jun 26, 2017
Registered-Sec.71 Accepted
May 23, 2017
Registered-Sec.71 Filed
Jun 26, 2017
Registered - Sec. 15 Acknowledged
May 23, 2017
Registered - Sec. 15 Affidavit Filed
Jun 26, 2017
Case Assigned To Post Registration Paralegal
May 23, 2017
Teas Section 71 Received
May 23, 2017
Teas Section 15 Received
Aug 15, 2014
New Representative At Ib Received
Mar 3, 2013
Final Decision Transaction Processed By Ib
Dec 2, 2011
Final Disposition Notice Sent To Ib
Dec 1, 2011
Final Disposition Processed
Sep 28, 2011
Final Disposition Notice Created, To Be Sent To Ib
Jun 28, 2011
Registered-Principal Register
Apr 16, 2011
Notification Of Possible Opposition - Processed By Ib
Apr 12, 2011
Official Gazette Publication Confirmation E-Mailed
Apr 12, 2011
Published For Opposition
Mar 24, 2011
Notification Of Possible Opposition Sent To Ib
Mar 24, 2011
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 5, 2011
Law Office Publication Review Completed
Mar 5, 2011
Assigned To Lie
Feb 8, 2011
Approved For Pub - Principal Register
Feb 8, 2011
Examiner's Amendment Entered
Feb 8, 2011
Notification Of Examiners Amendment E-Mailed
Feb 8, 2011
Examiners Amendment E-Mailed
Feb 8, 2011
Examiners Amendment -Written
Jan 28, 2011
Notification Of Possible Opposition - Processed By Ib
Jan 13, 2011
Notification Of Possible Opposition Sent To Ib
Jan 13, 2011
Notification Of Possible Opposition Created, To Be Sent To Ib
Dec 8, 2010
Notification Of Priority Action E-Mailed
Dec 8, 2010
Priority Action E-Mailed
Dec 8, 2010
Priority Action Written
Sep 28, 2010
Teas/Email Correspondence Entered
Sep 27, 2010
Correspondence Received In Law Office
Sep 27, 2010
Teas Response To Office Action Received
Mar 26, 2010
Notification Of Non-Final Action E-Mailed
Mar 26, 2010
Non-Final Action E-Mailed
Mar 26, 2010
Non-Final Action Written
Mar 3, 2010
Teas/Email Correspondence Entered
Mar 3, 2010
Correspondence Received In Law Office
Mar 1, 2010
Assigned To Lie
Feb 27, 2010
Teas Response To Office Action Received
Feb 17, 2010
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 17, 2010
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 29, 2009
Refusal Processed By Ib
Aug 27, 2009
Non-Final Action Mailed - Refusal Sent To Ib
Aug 27, 2009
Refusal Processed By Mpu
Aug 25, 2009
Non-Final Action (Ib Refusal) Prepared For Review
Aug 24, 2009
Non-Final Action Written
Aug 18, 2009
Application Filing Receipt Mailed
Aug 14, 2009
Assigned To Examiner
Aug 14, 2009
New Application Office Supplied Data Entered In Tram
Aug 13, 2009
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
